Submit to JCM Review for JCM Propose a Special Issue

Journal Menu

Journal Browser

Pleuroparenchymal Fibroelastosis: Obstacles and Challenges

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Benefits of Publishing in a Special Issue
Published Papers

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 17895

Share This Special Issue

Special Issue Editor

Prof. Dr. Hiroshi Ishii

E-Mail Website
Guest Editor

Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Fukuoka, Japan
Interests: interstitial pneumonia; pulmonary fibrosis; connective tissue disease-related interstitial lung disease

Special Issue Information

Dear Colleagues,

The field of pleuroparenchymal fibroelastosisis (PPFE) research is growing rapidly. PPFE is a rare interstitial pneumonia consisting of alveolar septal elastosis and intra-alveolar collagenosis, predominantly located in the upper lobes. Recent discoveries suggest that the clinical and physiological characteristics of upper lobe fibroelastosis differ from those of idiopathic pulmonary fibrosis (IPF), including a flattened thoracic cage and a marked decrease in forced vital capacity, but with preserved residual volume. The prognosis may be related to the development of fibrosing interstitial pneumonia in the lower lobes. However, there is marked variation in the pathogenesis and clinical features of PPFE. Although the diagnostic criteria for PPFE are based on histological findings by surgical lung biopsy (SLB), we have limited chances to perform an SLB for the diagnosis of PPFE. A proposal concerning the diagnostic criteria for idiopathic PPFE with and without an SLB was recently published. However, there are no established blood biomarkers to aid in the diagnosis or prediction of a progressive phenotype in PPFE patients. Mechanisms of the occurrence and evolution of fibroelastosis in PPFE are still unknown. In addition, treatment strategies for PPFE, targeting the inhibition of elastosis, have not been established. The present Special Issue aims to deepen our understanding of the characteristics of PPFE to increase our knowledge of a, so far, poorly explored research area, and to seek innovative treatment of PPFE.

Prof. Dr. Hiroshi Ishii
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

peuroparenchymal fibroelastosis
clinical and physiological findings
prognostic predictor
histological characteristics
predisposing factors or comorbidities
pathogenic mechanism
biomarker/molecular target

Benefits of Publishing in a Special Issue

Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (6 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Review

9 pages, 636 KiB

Open AccessArticle

Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes

by Yutaro Nakamura, Kazutaka Mori, Yasunori Enomoto, Masato Kono, Hiromitsu Sumikawa, Takeshi Johkoh, Thomas V. Colby, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Yusuke Kaida, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Takashi Yamada, Toshihiro Shirai, Hidenori Nakamura, Hiroshi Hayakawa and Takafumi Suda Show full author list Hide full author list

J. Clin. Med. 2021, 10(7), 1498; https://doi.org/10.3390/jcm10071498 - 4 Apr 2021

Cited by 9 | Viewed by 2595

Abstract

Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a distinctive interstitial pneumonia with upper lobe predominance that shows unique morphological features among idiopathic interstitial pneumonias (IIPs). Affected patients have a variety of clinical presentations with heterogeneous clinical courses. Cluster analysis is a valuable tool for identifying distinct clinical phenotypes under heterogeneous conditions. This study aimed to identify the phenotypes of patients with idiopathic PPFE. Using cluster analysis, novel PPFE phenotypes were identified among subjects from our multicenter cohort, and outcomes were stratified according to phenotypic clusters. Among the subjects with baseline data (N = 84), four clusters were identified. Cluster 1 included younger male subjects with coexisting non-UIP-like patterns. Cluster 2 included elderly female nonsmokers with low body mass index (BMI). Cluster 3 included elderly male smokers with a coexisting IP-like pattern. Cluster 4 included younger male smokers without lower lobe lesions. Patients in cluster 3 had significantly worse survival outcomes than those in clusters 1, 2, and 4 (p < 0.001, p = 0.0041, and p = 0.0155, respectively). Among idiopathic PPFE patients, cluster analysis using baseline characteristics identified four distinct clinical phenotypes that might predict survival outcomes. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Figure 1

14 pages, 7234 KiB

Open AccessArticle

Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study

by Jesper Rømhild Davidsen, Christian B. Laursen, Mikkel Højlund, Thomas Kromann Lund, Klaus Nielsen Jeschke, Martin Iversen, Anna Kalhauge, Elisabeth Bendstrup, Jørn Carlsen, Michael Perch, Daniel Pilsgaard Henriksen and Hans Henrik Lawaetz Schultz

J. Clin. Med. 2021, 10(5), 1078; https://doi.org/10.3390/jcm10051078 - 5 Mar 2021

Cited by 9 | Viewed by 3312

Abstract

Background: Bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS) are two distinct phenotypes of chronic lung allograft dysfunction (CLAD) in lung transplant (LTx) recipients. Contrary to BOS, RAS can radiologically present with a pleuroparenchymal fibroelastosis (PPFE) pattern. This study investigates lung ultrasound (LUS) to identify potential surrogate markers of PPFE in order to distinguish CLAD phenotype RAS from BOS. Methods: A prospective cohort study performed at a National Lung Transplantation Center during June 2016 to December 2017. Patients were examined with LUS and high-resolution computed tomography of the thorax (HRCT). Results: Twenty-five CLAD patients (72% males, median age of 54 years) were included, corresponding to 19/6 BOS/RAS patients. LUS-identified pleural thickening was more pronounced in RAS vs. BOS patients (5.6 vs. 2.9 mm) compatible with PPFE on HRCT. LUS-identified pleural thickening as an indicator of PPFE in RAS patients’ upper lobes showed a sensitivity of 100% (95% CI; 54–100%), specificity of 100% (95% CI; 82–100%), PPV of 100% (95% CI; 54–100%), and NPV of 100% (95% CI; 82–100%). Conclusion: Apical pleural thickening detected by LUS and compatible with PPFE on HRCT separates RAS from BOS in patients with CLAD. We propose LUS as a supplementary tool for initial CLAD phenotyping. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Figure 1

10 pages, 4344 KiB

Open AccessArticle

Alveolar Epithelial Denudation Is a Major Factor in the Pathogenesis of Pleuroparenchymal Fibroelastosis

by Yoshiaki Zaizen, Yuri Tachibana, Yukio Kashima, Andrey Bychkov, Kazuhiro Tabata, Kyoko Otani, Yoshiaki Kinoshita, Yasuhiko Yamano, Kensuke Kataoka, Kazuya Ichikado, Masaki Okamoto, Tomoo Kishaba, Remi Mito, Koichi Nishimura, Mari Yamasue, Kazuki Nabeshima, Kentaro Watanabe, Yasuhiro Kondoh and Junya Fukuoka

J. Clin. Med. 2021, 10(5), 895; https://doi.org/10.3390/jcm10050895 - 24 Feb 2021

Cited by 4 | Viewed by 2922

Abstract

The pathogenesis of pleuroparenchymal fibroelastosis (PPFE), a rare interstitial lung disease, remains unclear. Based on previous reports and our experience, we hypothesized that alveolar epithelial denudation (AED) was involved in the pathogenesis of PPFE. This multicenter retrospective study investigated the percentage of AED and the features of the denudated areas in 26 PPFE cases, 30 idiopathic pulmonary fibrosis (IPF) cases, and 29 controls. PPFE patients had lower forced vital capacities and higher residual volume/total lung capacities in pulmonary function tests compared to IPF and control patients. Histopathologically, subpleural fibroelastosis was observed in PPFE, and AED was observed in 12.01% of cases in the subpleural or interlobular septa regardless of fibroelastosis. The percentage of AED in the PPFE group was significantly higher than that in the IPF group (6.84%; p = 0.03) and the normal group (1.19%; p < 0.001). In the IPF group, the percentage of AED and the presence of PPFE-like lesions in the upper lobes were examined radiologically, but no correlation was found. We showed that AED frequently occurred in PPFE. AED was less frequent in IPF, which, in combination with imaging data, suggests that PPFE may have a different pathogenesis from IPF. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Figure 1

11 pages, 4241 KiB

Open AccessArticle

Comparison of Clinical Characteristics and Outcomes between Idiopathic and Secondary Pleuroparenchymal Fibroelastosis

by Tsuneyuki Oda, Akimasa Sekine, Erina Tabata, Tae Iwasawa, Tamiko Takemura and Takashi Ogura

J. Clin. Med. 2021, 10(4), 846; https://doi.org/10.3390/jcm10040846 - 18 Feb 2021

Cited by 13 | Viewed by 2423

Abstract

Background: Pleuroparenchymal fibroelastosis (PPFE) is a unique clinical, radiologic, and histopathologic entity for which several potential etiologies have been reported recently. However, there has been no comprehensive study of secondary PPFE. Objective: Assessment of the clinical characteristics, outcomes, and prognostic factors of secondary and idiopathic PPFE. Methods: We retrospectively reviewed the medical records of consecutive PPFE patients between January 1999 and December 2018. We identified 132 idiopathic PPFE patients and 32 secondary PPFE patients. Results: The incidence of interstitial lung disease (ILD) pattern different from the usual interstitial pneumonia (UIP) pattern in the lower lobes was higher in secondary PPFE patients (38.5%) than in idiopathic PPFE patients (61.5%, p = 0.02). The idiopathic and secondary PPFE groups did not differ significantly in terms of laboratory data, respiratory complications, and survival (median: 5.0 years vs. 4.1 years, p = 0.95). The presence of UIP pattern was independently associated with increased mortality in multivariate analyses in idiopathic PPFE patients, but not in secondary PPFE patients. Conclusions: The frequency and prognostic impact of UIP-pattern ILD differed between idiopathic and secondary PPFE patients. Lung transplantation should be considered in secondary PPFE patients with low diffusing capacity of the lungs for carbon monoxide (DLCO) regardless of lower-lobe ILD pattern. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Figure 1

12 pages, 2681 KiB

Open AccessFeature PaperArticle

Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis

by Takato Ikeda, Yoshiaki Kinoshita, Yusuke Ueda, Tomoya Sasaki, Hisako Kushima and Hiroshi Ishii

J. Clin. Med. 2020, 9(11), 3761; https://doi.org/10.3390/jcm9113761 - 22 Nov 2020

Cited by 9 | Viewed by 2384

Abstract

Background: Diagnostic criteria of idiopathic pleuroparenchymal fibroelastosis (IPPFE) were recently proposed, including physiological criteria of the body mass index (BMI) and percentage of the predicted values of residual volume (RV)/total lung capacity (TLC) (RV/TLC %pred.). The aim of this study was to evaluate (i) whether the physiologic criteria are useful for the diagnosis and (ii) whether the flat chest index, defined as the ratio of the anteroposterior diameter to the transverse diameter of the thoracic cage, could be an alternative parameter to RV/TLC %pred. Methods: We selected consecutive IPPFE patients and idiopathic pulmonary fibrosis (IPF) patients. We examined the diagnostic sensitivity and specificity of the physiological criteria and flat chest index for differentiating IPPFE patients from IPF patients. Results: This study included 37 IPPFE patients and 89 IPF patients. The physiological criteria distinguished IPPFE patients from IPF patients with a sensitivity of 78.6% and specificity of 88.0%. The combination of the flat chest index and BMI was also effective for differentiation (sensitivity of 82.1% and specificity of 89.3%). Conclusion: We verified the good performance of the physiologic criteria in a different cohort. When the RV/TLC is not measured, using the flat chest index instead of RV/TLC %pred. may be reasonable. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Figure 1

Review

Jump to: Research

9 pages, 911 KiB

Open AccessReview

Lung Transplantation for Pleuroparenchymal Fibroelastosis

by Haruhiko Shiiya and Masaaki Sato

J. Clin. Med. 2021, 10(5), 957; https://doi.org/10.3390/jcm10050957 - 1 Mar 2021

Cited by 9 | Viewed by 3018

Abstract

Pleuroparenchymal fibroelastosis (PPFE), a new disease entity associated with interstitial pneumonia, is characterized by fibrosis and elastosis involving the pleura and subpleural lung parenchyma, predominantly in the upper lobe. As the awareness of this disease entity has increased, many studies have revealed the prevalence and incidence, clinical and pathological characteristics, and disease course of PPFE. Patients with PPFE reportedly have several unique clinical characteristics—including an extremely low body mass index with a slender body and chest wall deformity, known as “flat chest”. As this disease progresses, shrinking of the lungs often causes life-threatening complications, such as pneumothorax, and associated air leak syndrome. Lung transplantation is considered the only effective treatment for patients with advanced PPFE; however, little is known about the influences of the characteristics of PPFE on the outcome of lung transplantation. This review focuses on the unique clinicopathologic characteristics of PPFE and associated outcomes of lung transplantation for these patients. Full article

(This article belongs to the Special Issue Pleuroparenchymal Fibroelastosis: Obstacles and Challenges)

► Show Figures

Journal Menu

Journal Browser

Pleuroparenchymal Fibroelastosis: Obstacles and Challenges

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Benefits of Publishing in a Special Issue

Published Papers (6 papers)

Research

Review

Further Information

Guidelines

MDPI Initiatives

Follow MDPI